K910270Substantially Equivalent
Premixed Dialysate for Hemodiafiltration
Baxter Healthcare Corporation, Round Lake IL / Traditional, Substantially Equivalent
K910270 is the FDA 510(k) clearance record for PREMIXED DIALYSATE FOR HEMODIAFILTRATION, a class II device, cleared for Baxter Healthcare Corp on under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)). FDA records list 570 510(k) clearances for Baxter Healthcare Corp, from to . As of , FDA records show no recalls naming K910270.
Clearance record
- Decision date
- Received
- (85 days to decision)
- Product code
- KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Regulation
- 21 CFR 876.5820
- Device class
- Class II
- Review panel
- Gastroenterology, Urology
- Applicant
- Baxter Healthcare Corp Rte. 120 And Wilson Rd., Round Lake IL
- Third party review
- No
Clearances, product code KPO
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| December 2025 | 0 |
| January 2026 | 1 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 1 |
| September 2026 | 0 |
| October 2026 | 0 |
| November 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
